Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2
Phase 1Completed 0 watching 0 views this week💤 Quiet
30
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Contraceptives, Postcoital
Conditions
Contraceptives, Postcoital
Trial Timeline
Sep 1, 2009 → Sep 1, 2009
NCT ID
NCT01073904About Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2
Levonorgestrel Emergency Pill (BAY86-5028) + Postinor 2 is a phase 1 stage product being developed by Bayer for Contraceptives, Postcoital. The current trial status is completed. This product is registered under clinical trial identifier NCT01073904. Target conditions include Contraceptives, Postcoital.
Hype Score Breakdown
Clinical
10
Activity
5
Company
7
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01073904 | Phase 1 | Completed |
Competing Products
4 competing products in Contraceptives, Postcoital
| Product | Company | Stage | Hype Score |
|---|---|---|---|
| AZD1981 + Neovletta 21/28 + Placebo AZD1981 | AstraZeneca | Phase 1 | 33 |
| Leios/Alesse | Pfizer | Pre-clinical | 22 |
| EV/DNG (Qlaira, BAY86-5027) + Progestin Only Pills | Bayer | Pre-clinical | 20 |
| YAZ (DRSP 3 mg/EE 0.02 mg, BAY86-5300) + Yasminelle (SH T 00186 D) | Bayer | Phase 2 | 49 |